Ovarian Cancer by FIGO Stage
2 clinical trials · Condition
◉ Watch Ovarian Cancer by FIGO Stage
| Record | Firm | Date |
|---|---|---|
| Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer (NCT04938583) | CanariaBio Inc. | 2021-03-17 |
Track Ovarian Cancer by FIGO Stage automatically
Every clearance here is in the API, with alerts when new ones post.